Cabergoline in Parkinson's disease: long-term follow-up.

Lera, G; Vaamonde, J; Rodriguez, M; Obeso, J A

Lera, G; Vaamonde, J; Rodriguez, M; Obeso, J A.

Affiliation

Lera G; Department of Neurology, University of Navarra, Pamplona, Spain.

Neurology ; 43(12): 2587-90, 1993 Dec.

Article in En | MEDLINE | ID: mdl-7902970

Subject(s)

Ergolines/therapeutic use; Parkinson Disease/drug therapy; Adult; Aged; Cabergoline; Dopamine Agents/therapeutic use; Drug Therapy, Combination; Ergolines/adverse effects; Ergolines/blood; Female; Follow-Up Studies; Humans; Levodopa/therapeutic use; Longitudinal Studies; Male; Middle Aged; Parkinson Disease/physiopathology; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Ergolines Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Neurology Year: 1993 Document type: Article

Search on Google

XML

PubMed Links